The RheumNow Week in Review – 2 December 2016 Save

Dr. Cush highlights reports from this week on RheumNow.com.

1. Tofacitinib is not associated with a higher risk of malignancy. http://buff.ly/2gxtB1q
2. Men (not women) with obesity or abdominal obesity have a 2-5 time higher risk of developing RA, especialy after age 50 yrs https://t.co/CUw3qo2CBC
3. Takeda 2 yr study of 314 early gout patients showed less acute flares with febuxostat vs placebo (29% v 41%), but not in 1st 6mos. of the study. https://t.co/oTCYXyEX6o
4. Study shows that only 1/5 of seniors receive shingles vaccine https://t.co/urTtxoc4MH
5. UK study shows that the risk of Giant Cell Arteritis is increased with increasing number of prior infections, less so Herpes zoster. https://t.co/1DGalYE8VU
6. Psoriatic arthritis sales may grow from $4.53billion (in 2015) to $12.6 billion (2025) in US, France, Germany, Italy,Spain,UK Japan https://t.co/IAt3KRHHlf
7. Claims data of over 500,000 people in metro areas shows that 58% RA patients have seen a rheumatologist and 64% were given a DMARD; but only 30% biologic pts had TB screening test  https://t.co/0lVzxCtdEW
8. ACR16 UCSF study shows Lupus patients affected by poverty have greater degree of organ damage vs not poor (1.97 vs 1.34). (Abstract#1958) https://t.co/uPnB6j3DK6
9. Turkish study of 1044 RA patients starting Remicade or Inflectra: More chose REM (80/20), and REM had fewer D/C's (27 vs 44%) Abstract #1233 https://t.co/gonuSZXop3
10. Lupus nephritis outcomes predicted by Selectivity Index (ratio urinary IgG/transferin clearance) Better outcomes w/ low SI index https://t.co/FkiJxQ5qez
11. ASDAS Activity Correlates with Xray Progression in Spondyloarthritis 
12. Statins for the Treatment of Osteoporosis
13. CURES Act: House Passes Largest Bill Since Obamacare 
14. Rheumatologist Compensation and Manpower
15. Early Rheumatology: The Contributions of Max Hirsch, MD